What is QuantumSi Inc?
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
QSI · Verdict
Moderate reward · elevated risk
QSI stands out on balance sheet and valuation, but watch the volatility signal.
Based on 88% data coverage
QSI · Verdict
Current ratio 11.99
Above average
Weak vs peers
-3021% free-cash-flow margin
-3303% net margin · -52% ROE
Model-based scoring. For information only — not financial advice.
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 206.09M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.